Facial Hyperpigmentation: A Rare Side Effect of Adalimumab

• Main Authors: Malek Mrad MD (Author), Mariam Tabka MD (Author), Asmahane Souissi MD (Author), Ines Chelly MD (Author), Mourad Mokni MD (Author)
• Format: Book
• Published: SAGE Publishing, 2024-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

This report describes a case of facial hyperpigmentation in a patient with Crohn's disease receiving adalimumab, a tumor necrosis factor (TNF)-alpha inhibitor. The onset of hyperpigmentation coincided with adalimumab administration, and its discontinuation resulted in significant improvement. H...